Hyperfine (HYPR) Interest & Investment Income (2021 - 2026)
Hyperfine (HYPR) posted Interest & Investment Income of $254000.0 for Q1 2026, down 9.29% on a QoQ basis from $280000.0 in Q4 2025, and down 19.87% year-over-year from $317000.0 in Q1 2025.
Hyperfine (HYPR) Interest & Investment Income (2021 - 2026) Analysis & Trends
Hyperfine's Interest & Investment Income history runs 6 years deep, the most recent figure standing at $254000.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 19.87% year-over-year to $254000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $960000.0 (down 52.31% YoY) and the FY2025 annual result came in at $1.0 million, down 58.95% from the prior year.
- Interest & Investment Income was $254000.0 for Q1 2026 at Hyperfine, down from $280000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.0 million in Q2 2023 and bottomed at $1000.0 in Q1 2022.
- A 5-year average of $492470.6 and a median of $436000.0 in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income sank 80.0% — and 2023, when it surged 86800.0%.
- Hyperfine's Interest & Investment Income stood at $558000.0 in 2022, then jumped by 65.23% to $922000.0 in 2023, then tumbled by 52.71% to $436000.0 in 2024, then tumbled by 35.78% to $280000.0 in 2025, then retreated by 9.29% to $254000.0 in 2026.
- Business Quant data shows HYPR's Interest & Investment Income at $254000.0 in Q1 2026, $280000.0 in Q4 2025, and $187000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Hyperfine | 94.51 Mn | 53.23 Mn | 1.98 Mn | 254,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 254,000.00 |
| Dec 31, 2025 | 280,000.00 |
| Sep 30, 2025 | 187,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Dec 31, 2024 | 436,000.00 |
| Sep 30, 2024 | 585,000.00 |
| Jun 30, 2024 | 675,000.00 |
| Mar 31, 2024 | 796,000.00 |
| Dec 31, 2023 | 922,000.00 |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 869,000.00 |
| Dec 31, 2022 | 558,000.00 |
| Sep 30, 2022 | 170,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 5,000.00 |